Why Rigel Pharma Is Making a Run
Shares of Rigel Pharmaceuticals skyrocketed early on Tuesday after the company reported incredibly positive results from its late-stage blood platelet clinical trial.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 199
An Outside View on St. Jude Device Cyberattack Woes
St. Jude Medical has issued a press release aimed at responding to points in the Muddy Waters report, and a Credit Suisse research report has dispelled some of the concerns.
Why AstraZeneca Could Gain Another 15% Despite Market Headwinds
Major pharmaceuticals have been under fire in light of the recent Mylan EpiPen pricing fiasco, but now a key research firm is seeing one of these companies in a positive light.
US Food and Drug Administration Approves Zika Test
From PR Newswire: Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the LightMix® Zika rRT-PCR Test. The product…
FDA Recommends Zika Test for All Blood Donations
The FDA has issued a recommendation for universal testing of donated whole blood and blood components for the Zika virus in the United States and its territories.
Sanofi Just Can’t Catch a Break, Knocking at Major Support Again
At this point, bad news is coming in consistently to the point that any significant piece of good news could catapult Sanofi stock higher, making it an interesting choice for dip-buyers.
Major Pharma Short Interest Faces Significant Drop
The August 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest has significantly decreased.
Short Sellers Increase Bets in Major Biotechs
The August 15 short interest data have been compared with the previous report, and short interest moves were mixed across these selected biotech stocks.
Concerns Persist on Mylan EpiPen Price Gouging — or Do They?
Mylan is under fire for price gouging on its EpiPen. There has been some concern that this was a serious mistake by CEO Heather Bresch.
How Analysts and Investors Are Chasing Clovis Higher and Higher, All Over Again
Clovis Oncology shares saw a massive gain on Tuesday, on the heels of news that the FDA had granted it a priority review of its cancer drug.
Federal Funding Approved for Rapid Zika Virus Test
Medical diagnostics maker OraSure Technologies said Tuesday night that it has been awarded a more than $16 million contract to proceed with work on the company's rapid tests for the Zika virus.
How Clovis Scored Big on a Milestone FDA Approval
Clovis Oncology, Inc. (NASDAQ: CLVS) is watching its shares climb late Tuesday after the company announced a key U.S. Food and Drug Administration (FDA) approval. Note that this is the first of a few…
Best Ways to Prevent Mosquito Bites — CDC
As fears that the mosquito-born Zika virus continue to spread, the CDC has several rules to cut the chance of mosquito bites.
Valeant Gains Momentum With New CFO Appointment
Shares of Valeant Pharmaceuticals saw a handy gain in Monday’s session after the company announced that it has appointed a new chief financial officer.
Pfizer Pays a Big Premium for Medivation
In one of the longest running bidding wars in recent times, Pfizer has finally reeled in cancer-drug maker Medivation.